Bodybuilding legend and former seven-time Mr. Olympia Arnold Schwarzenegger discussed if using GLP-1 drugs destroy lean ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

The country’s Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme, the UK’s official system for ...

As the popularity of medications for weight loss, such as Ozempic and Wegovy, surges across North America, new research ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A new oral drug may be able to treat type 2 diabetes and obesity without impacting muscle mass as an alternative to GLP-1 ...

A study published in the Journal of Medical Toxicology by researchers at the University of Alabama at Birmingham found that ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...

GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...